Michael Dell’s Family Office Invests in Tumor Treating Company
Posted on 03/14/2020
Exuma Biotech Corporation is the new name for F1 Oncology, Inc. Exuma Biotech is a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors. Exuma Biotech is working on discovery and development of Chimeric Antigen Receptor T cell (CAR-T) candidates for both solid and liquid tumor malignancies. Exuma Biotech raised US$ […]
